![]() Etonogestrel structure
|
Common Name | Etonogestrel | ||
---|---|---|---|---|
CAS Number | 54048-10-1 | Molecular Weight | 324.457 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 473.1±45.0 °C at 760 mmHg | |
Molecular Formula | C22H28O2 | Melting Point | 182-184ºC | |
MSDS | Chinese USA | Flash Point | 201.1±21.3 °C | |
Symbol |
![]() GHS08 |
Signal Word | Danger |
Name | etonogestrel |
---|---|
Synonym | More Synonyms |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 473.1±45.0 °C at 760 mmHg |
Melting Point | 182-184ºC |
Molecular Formula | C22H28O2 |
Molecular Weight | 324.457 |
Flash Point | 201.1±21.3 °C |
Exact Mass | 324.208923 |
PSA | 37.30000 |
LogP | 4.22 |
Vapour Pressure | 0.0±2.7 mmHg at 25°C |
Index of Refraction | 1.575 |
Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
![]() GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H351-H360 |
Precautionary Statements | P201-P280-P308 + P313 |
Hazard Codes | Xn |
Risk Phrases | 60-40 |
RIDADR | NONH for all modes of transport |
RTECS | JF8290000 |
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Contraception 90(2) , 123-9, (2014) The potential effect of hormonal contraception on HIV-1 acquisition and transmission represents an important public health issue. Several observational studies have suggested an association between th... |
|
Newer non-oral hormonal contraception.
BMJ 346 , f341, (2013)
|
|
The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.
Expert Opin. Pharmacother. 8(11) , 1769-77, (2007) Many factors influence the effectiveness of contraceptive methods. Oral contraceptives are the second most popular contraceptive method after female sterilization in the US. A total of 25% of women do... |
EINECS 258-936-2 |
3-Ketodesogestrel,3-Oxodesogestrel,Org-3236,Implanon |
Etonoestrel |
3-Keto-desogestrel 3-Oxo-desogestrel |
(17a)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one |
3-Oxodesogestrel |
3-Keto-Org 2969 |
18,19-Dinor-17α-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene- |
3-keto-desogestrel |
(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one |
13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-3-one |
3-Ketodesogestrel |
Etonogestrel |
Nexplanon |
Desogestrel Related Compound C (25 mg) (3-Keto-desogestrel) |
(8S,9S,10R,13S,14S,17R)-17-Ethinyl-13-ethyl-17-hydroxy-11-methyliden-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-on |
UNII-304GTH6RNH |
MFCD00867863 |
Implanon |
[3H]-3-keto-Desogestrel |
org3236 |
(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name) |
17-Ethinyl-17b-hydroxy-18-methyl-11-methylene-4-estren-3-one |
(8S,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-11-methylene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one |